Compounds useful for treating aids

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9908869
SERIAL NO

14256334

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound having the following formula or a pharmaceutically acceptable salt thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABIVAX;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSTITUT CURIE;UNIVERSITE DE MONTPELLIER

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Campos, Noelie Le Cres, FR 9 95
Garcel, Aude Le Cres, FR 16 120
Mahuteau, Florence Saint Remy les Chevreuses, FR 29 182
Najman, Romain L'Hay-les-Roses, FR 38 193
Scherrer, Didier Castelnau le Lez, FR 46 194
Tazi, Jamal Clapiers, FR 50 248

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00